相关实验视频
Updated: Jun 26, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.2K
血管功能在心力衰竭患者预后中的作用
Shunsuke Kiuchi1, Shinji Hisatake1, Shintaro Dobashi1
1Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo 143-8541, Japan.
Journal of clinical medicine
|May 11, 2024
概括
高心血管指数 (CAVI),衡量血管硬度,表明心力衰竭 (HF) 患者的预后不佳. 早期识别和仔细管理对于改善这些个体的结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 内部医学 内部医学
背景情况:
- 血管的风效应对血液循环至关重要,其功能障碍有助于心力衰竭 (HF) 的发病.
- 血管功能障碍和HF预后之间的确切联系仍然不完全理解.
研究的目的:
- 在住院心力衰竭患者中,通过心血管指数 (CAVI) 评估的血管功能与主要不良心脏事件 (MACE) 之间的关联.
主要方法:
- 在2012年1月至2018年7月期间,一组214名住院HF患者接受了CAVI评估.
- 收集了临床数据,实验室测试,成像和心声扫描,以确定出院后一年内MACE (心血管死亡或HF再入院) 的预测因素.
主要成果:
- 与没有MACE的患者相比,经历MACE的患者的CAVI和%平均心房压高.
- 在MACE组中观察到心脏阴影尺寸增加,左心室尺寸更大,并且在MACE组中观察到具有保留射出分数的HF患病率更高.
- 多变量分析证实CAVI是MACE的独立预测因子 (HR: 1.31-1.33,p=0.009-0.018).
结论:
- 升高的CAVI显著与心力衰竭患者的预后较差有关.
- 这些发现强调需要对高CAVI的HF患者进行更密切的监测和量身定制的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Pathophysiology of Cardiac Performance
644
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
644
Vascular Resistance
3.8K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.8K

